- Sarilumab, sold
under the
brand name
Kevzara, is a
human monoclonal antibody medication against the interleukin-6 receptor.
Regeneron Pharmaceuticals...
-
approved by the FDA in
March 2017 and is
reported to cost $37,000 per year.
Kevzara (sarilumab injection) is an interleukin-6 (IL-6)
receptor antagonist for...
-
Cerdelga Cerezyme Clolar Dupixent Elitek Eloctate Eloxatin Fabrazyme Jevtana Kevzara Lemtrada Libtayo Lumizyme Sarclisa Taxotare Zaltrap Genzyme has
spent more...
- by
Arbor Pharmaceuticals.
Jevtana (Cabazitaxel), for
prostate cancer.
Kevzara (Sarilumab), for
blood tests, lung and
prostate cancer,
marketed by Regeneron...
-
cancer Samrotamab vedotin mab chimeric/
humanized LRRC15
cancer Sarilumab Kevzara mab
human IL-6 Y
rheumatoid arthritis,
ankylosing spondylitis Satralizumab...
- 2/3
trial with the
partnership Sanofi, to
evaluate the
antibody agent,
Kevzara(TM) for
hospitalized patients starting in
March 2020, as well as, working...
-
large B-cell
lymphoma Chronic lymphocytic leukemia 761064 Link
sarilumab Kevzara Sanofi Aventis 5/22/17
subcutaneous fully human IL6R
Rheumatoid arthritis...
- (INN)
ketotifen (INN)
ketotrexate (INN)
ketoxal (INN)
Ketozole Keveyis Kevzara Keytruda Khapzory Khedezla k****in (INN) k****oside (INN)
Kimidess Kimmtrak...
- "Fillanthrop". 30 July 2010. "Regeneron,
Sanofi Launch Clinical Trial of
Kevzara as
Coronavirus Treatment". GEN -
Genetic Engineering and Biotechnology...
-
Archived from the
original on 28 July 2020.
Retrieved 6
April 2020. "
Kevzara". Drugs.com. 7
March 2019.
Archived from the
original on 28 July 2020....
